🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the efficacy of BIIB104 i...
Status
Completed
Location
Pillar Clinical Research, LLC
Start Date
2018-11-15
Trial ID
NCT03745820
ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-05-08
Trial ID
NCT04401579
Treatments Being Tested
The primary purpose of this study was to evaluate the effect of ESN364 on t...
Status
Completed
Location
Site BE32004
Start Date
2015-09-21
Trial ID
NCT05419908
Treatments Being Tested
This randomized, multicenter, double-blind, placebo-controlled, parallel-gr...
Status
Completed
Location
University Alabama At Birmingham
Start Date
2013-10-13
Trial ID
NCT01872689
Treatments Being Tested
A Dose Escalating Study of PRS-060 Administered by Oral Inhalation or IV In...
Status
Completed
Location
Nucleus Network Limited
Start Date
2017-12-08
Trial ID
NCT03384290
This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 ...
Status
Completed
Location
Thomas Hospital
Start Date
2024-03-01
Trial ID
NCT06264310
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
Clinical Site
Start Date
2023-03-13
Trial ID
NCT05766813
Treatments Being Tested
This study evaluates the safety and tolerability of treatment with K0706 in...
Status
Terminated
Location
MedStar Georgetown University Hospital
Start Date
2019-09-05
Trial ID
NCT03996460
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness (level of pain c...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00455520
The purpose of this study is to compare the efficacy of BHV-3000 (rimegepan...
Status
Completed
Location
Central Research Associates, Inc
Start Date
2017-07-18
Trial ID
NCT03235479
Treatments Being Tested